CD20-targeting monoclonal antibody in combination with chemotherapy
This page covers all CD20-targeting monoclonal antibody in combination with chemotherapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD20.
Targets
Phase 3 pipeline (1)
- RCHOP o R-miniCHOP at standard doses · Fondazione Italiana Linfomi - ETS · Oncology
R-CHOP and R-miniCHOP combine chemotherapy and a monoclonal antibody targeting CD20 on B cells.
Patent intelligence
- cd20 targeting monoclonal antibody in combination with chemotherapy patent landscape — aggregated cliff calendar, attackable patents, originator estates